Posted by Michael Wonder on 08 Feb 2021
SMC - February 2021 decisions
8 February 2021 - The SMC, which advises on newly licensed medicines for use by NHSScotland, has today published advice on four new medicines.
Afamelanotide (Scenesse) will be available for patients with erythropoietic protoporphyria through the ultra-orphan pathway, which supports access to medicines for extremely rare conditions.
